APA

Overgaard J., Radacic M., Skaric D., Skaric V., Horsman M. R., Lindegaard J. C. & Jercic J. (19940322). Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment. : International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Chicago

Overgaard J, Radacic M, Skaric D, Skaric V, Horsman M R, Lindegaard J C and Jercic J. 19940322. Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment. : International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Harvard

Overgaard J., Radacic M., Skaric D., Skaric V., Horsman M. R., Lindegaard J. C. and Jercic J. (19940322). Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment. : International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

MLA

Overgaard J, Radacic M, Skaric D, Skaric V, Horsman M R, Lindegaard J C and Jercic J. Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment. : International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 19940322.